CurAegis (CRGS) 10-Q 10 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 09, 2017
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	1,063,197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		47,769,265
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and equivalents	$ 892,000	$ 2,009,000
Accounts receivable		10,000
Inventory	35,000	24,000
Prepaid expenses and other current assets	44,000	48,000
Total current assets	971,000	2,091,000
Software (net)	196,000	227,000
Property and equipment (net)	114,000	117,000
Total non-current assets	310,000	344,000
Total Assets	1,281,000	2,435,000
Current Liabilities:
Accounts payable	150,000	143,000
Other current liabilities	179,000	103,000
Deferred revenue	15,000	22,000
Accrued interest	80,000	35,000
Capital lease obligation - current	2,000	2,000
Total current liabilities	426,000	305,000
Capital lease obligation, non-current	4,000	4,000
Convertible Debt, Noncurrent	655,000	543,000
Total Liabilities	1,085,000	852,000
Commitments and other matters (Note 11)
Stockholders' Equity:
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at March 31, 2017 and December 31, 2016: 47,369,265 and 47,066,765, respectively	474,000	470,000
Additional paid-in capital	76,179,000	76,065,000
Accumulated deficit	(76,920,000)	(75,418,000)
Stockholders' Equity Attributable to Parent	196,000	1,583,000
Total Liabilities and Stockholders' Equity	1,281,000	2,435,000
Preferred Class C [Member]
Stockholders' Equity:
Preferred stock, value	159,000	160,000
Series C2 Preferred Stock [Member]
Stockholders' Equity:
Preferred stock, value	250,000	250,000
Series C3 Preferred Stock [Member]
Stockholders' Equity:
Preferred stock, value	48,000	50,000
Preferred Class A [Member]
Stockholders' Equity:
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Stockholders' Equity:
Preferred stock, value	$ 1,000	$ 1,000

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	47,369,265	47,066,765
Common stock, shares outstanding (in shares)	47,369,265	47,066,765
Preferred Class C [Member]
Preferred stock, shares authorized (in shares)	16,000,000	16,250,000
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	15,937,500	16,000,000
Preferred stock, shares outstanding (in shares)	15,937,500	16,000,000
Series C2 Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	25,000,000	25,000,000
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	25,000,000	25,000,000
Preferred stock, shares outstanding (in shares)	25,000,000	25,000,000
Series C3 Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	4,822,000	5,022,000
Preferred stock, shares outstanding (in shares)	4,822,000	5,022,000
Preferred Class A [Member]
Preferred stock, shares authorized (in shares)	3,300,000	3,300,000
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.40	$ 0.40
Preferred stock, shares issued (in shares)	543,221	543,221
Preferred stock, shares outstanding (in shares)	543,221	543,221
Preferred Class B [Member]
Preferred stock, shares authorized (in shares)	300,000	300,000
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.50	$ 0.50
Preferred stock, shares issued (in shares)	67,500	67,500
Preferred stock, shares outstanding (in shares)	67,500	67,500

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue	$ 9,000	$ 1,000
Cost of revenue	37,000	23,000
Loss on Revenue	(28,000)	(22,000)
Engineering and development:
E&D costs, excluding stock-based compensation	485,000	485,000
Stock-based compensation	8,000	7,000
Total engineering and development	493,000	492,000
General and administrative:
G&A costs, excluding stock-based compensation	730,000	400,000
Stock-based compensation	95,000	24,000
Total general and administrative	825,000	424,000
Total costs and expenses	1,318,000	916,000
Loss from operations	(1,346,000)	(938,000)
Interest expense	(156,000)
Other income	1,000	1,000
Non-operating (expense) income	(155,000)	1,000
Loss before income taxes	(1,501,000)	(937,000)
Income taxes
Net Loss	(1,501,000)	(937,000)
Preferred stock beneficial conversion feature		549,000
Preferred stock dividends	62,000	62,000
Net Loss attributable to common stockholders	$ (1,563,000)	$ (1,548,000)
Net Loss per share attributable to common stockholders:
Basic and Diluted (in dollars per share)	$ (0.03)	$ (0.03)
Weighted average number of shares of common stock:
Basic and Diluted (in shares)	47,161,000	45,796,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Stockholders Equity (Unaudited) - 3 months ended Mar. 31, 2017 - USD ($)	Series C3 Preferred Stock [Member]Preferred Stock [Member]	Series C3 Preferred Stock [Member]Common Stock [Member]	Series C Preferred Stock [Member]Preferred Stock [Member]	Series C Preferred Stock [Member]Common Stock [Member]	Series C Preferred Stock [Member]	Series C2 Preferred Stock [Member]Preferred Stock [Member]	Preferred Class A [Member]Preferred Stock [Member]	Preferred Class B [Member]Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2016	5,022,000		16,000,000			25,000,000	543,221	67,500	47,066,765
Balance at Dec. 31, 2016	$ 50,000		$ 160,000			$ 250,000	$ 5,000	$ 1,000	$ 470,000	$ 76,065,000	$ (75,418,000)	$ 1,583,000
Conversion of preferred shares into common shares (in shares)	(200,000)	200,000	(62,500)	62,500
Conversion of preferred shares into common shares	$ (2,000)	$ 2,000	$ (1,000)	$ 1,000
Exercise of Common Stock warrant (in shares)					15,937,500				40,000
Exercise of Common Stock warrant										10,000		10,000
Stock Based Compensation										103,000		103,000
Net loss											(1,501,000)	(1,501,000)
Rounding Adjustment									$ 1,000	1,000	(1,000)	1,000
Balance (in shares) at Mar. 31, 2017	4,822,000		15,937,500			25,000,000	543,221	67,500	47,369,265
Balance at Mar. 31, 2017	$ 48,000		$ 159,000			$ 250,000	$ 5,000	$ 1,000	$ 474,000	$ 76,179,000	$ (76,920,000)	$ 196,000

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (1,501,000)	$ (937,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, Depletion and Amortization	46,000	41,000
Amortization of Debt Discount (Premium)	112,000
Stock-based compensation	103,000	31,000
Accounts receivable	10,000	(1,000)
Inventory	(11,000)
Prepaid expenses and other current assets	4,000	(7,000)
Accounts payable and other accrued expenses	128,000	71,000
Deferred revenue	(7,000)	9,000
Net cash used in operating activities	(1,116,000)	(793,000)
Cash flows from investing activities:
Purchase of property, equipment and software	(11,000)	(15,000)
Net cash used in investing activities	(11,000)	(15,000)
Cash flows from financing activities:
Proceeds from sales of preferred stock		1,119,000
Costs incurred in issuance of preferred stock		(5,000)
Proceeds from exercise of common stock warrant	10,000
Net cash provided by financing activities	10,000	1,114,000
Net (decrease) increase in cash and cash equivalents	(1,117,000)	306,000
Cash and cash equivalents at beginning of period	2,009,000	1,241,000
Cash and cash equivalents at end of period	$ 892,000	$ 1,547,000

Note 1 - The Company and Basis

Note 1 - The Company and Basis of Presentation	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 — THE COMPANY AND BASIS OF PRESENTATION CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation on September 25, 1996 June 2016 two The Company develops and markets advanced technologies in the areas of safety , wellness and power. The Company is focused on the commercialization of a wellness and safety system (the CURA system and the myCadian watch) and a uniquely designed hydraulic pump that will be smaller, lighter and more efficient than current technology. The Company has not had any significant revenue-producing operations. The Company has created the CURA system to market products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA system consists of the following capabilities: ● the myCadian watch and app, ● real-time alertness monitoring, ● the Group Wellness Index and ● the Z-Coach wellness program . Our goal with the Aegis hydraulic pump technology is to bring to the marketplace a unique concept in hydraulic pumps and motors that will be: ● smaller and lighter than conventional pumps and motors, ● more efficient, ● as reliable, ● price competitive, and ● unique in its ability to scale larger, allowing more powerful pumps and motors. It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Management Plans As of March 31, 2017, $892,000, $545,000, $196,000 $76,920,000. December 31, 2016, $1,510,000 3 $3,000,000 6% Management estimates that the 2017 $4.0 $4.6 March 31, 2017, During the first 2017, 4(a)(2) 1934, 506(c) 501(a) 1933. $3 6% five $0.50 60% 90 10% $0.50 60% 90 Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No assurance can be given that necessary funds will be available for us to finance our development on acceptable terms, if at all. Furthermore, such additional financings may may may The Company ’s ability to fund its current and future commitments out of its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA division; and (ii) decrease engineering and development and administrative expenses. If these and other factors are not met, the Company would need to raise funds in order to meet its working capital needs and pursue its growth strategy. Although there can be no such assurances, management believes that sources for these additional funds will be available through either current or future investors.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation: 10 8 03 December 31, 2016 2016 10 Consolidation: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% March 31, 2017). March 31, 2017, Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates. Reclassifications: Certain reclassifications may Cash and Equivalents: Cash and equivalents may three may $25,000. Inventory : Inventory is stated at the lower of cost or market with cost determined under the average cost method. We record provisions for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. The allowance for excess, obsolete or slow-moving inventory was zero March 31, 2017 December 31, 2016. Accounts Receivable : We carry our accounts receivable at invoice amount less an allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and establish an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. We do not accrue interest on past due invoices. The allowance for doubtful accounts was zero March 31, 2017 December 31, 2016. Software, Property and Equipment: Capitalized software, property and equipment are stated at cost. Estimated useful lives are as follows: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the three March 31, 2017 2016 to $46,000 $41,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may three March 31, 2017 2016, no Fair Value of Financial Instruments: As defined by U.S. GAAP , one three Level 1: Level 2: Level 3: The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at March 31, 2017. 6% $12,600,000 March 31, 2017. Revenue Recognition and Deferred Revenue: The Company began offering the Z-Coach Aviation program in the first 2016. twelve 30 Engineering and Development and Patents: Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development includes personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the three March 31, 2017 2016 $30,000 $17,000, Stock-based Compensation: FASB Accounting Standards Codification (“ASC”) 718 10 may 718 10. FASB ASC 505 50, FASB ASC 718 20 Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified. Income Taxes: We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of March 31, 2017, December 31, 2016, no Loss per Common Share: FASB’s ASC 260 10 March 31, 2017 2016, 72,282,657 59,016,206 625,000 March 31, 2017 2016 Recent Accounting Pronouncements: FASB Accounting Pronouncements Related to Revenue from Contracts with Customers (Topic 606) In May 2014, 2014 09, 2014 09 2014 09 five may In May 2015, 2015 14, December 15, 2017. March 2016, 2016 08 April 2016, 2016 10, 606. May, 2016, 2016 12, 606. These standards are effective for annual periods beginning after December 15, 2017, The Company continues to evaluate the impact of the adoption of FASB accounting pronouncements related to revenue from Contracts with Customers (Topic 606) Other FASB Accounting Pronouncements In August 2016, 2016 15 Topic 230).” 230, eight December 15, 2017, In June 2016, 2016 13 326) December 15, 2019, On February 25, 2016, 2016 02, December 15, 2018,

Note 3 - 6% Senior Convertible

Note 3 - 6% Senior Convertible Notes and Warrants	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 3 6% During the third 2016, $3 6% 2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. first $0.25 August 25, 2016. 10% $0.25 ten 4(a)(2) 1934, 506(c) 501(a) 1933. The Company allocated $2,551,000 2016 three March 31, 2017 $156,000 $112,000. March 31, 2017, 2016 $3,000,000 $2,345,000 $655,000. During the first 2017, $3 6% “2017 April 2017 “2017 a five 6%. first $0.50 90 10% $0.50 90 ten 4(a)(2) 1934, 506(c) 501(a) 1933. three March 31, 2017, 2017 2017

Note 4 - Capital Lease Obligati

Note 4 - Capital Lease Obligation	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Capital Leases in Financial Statements of Lessee Disclosure [Text Block]	NOTE 4 In 2015, 5 $9,000 $170 5.3%. $2,000 2020.

Note 5 - Software

Note 5 - Software	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 5 SOFTWARE The Company has invested in software for the CURA System and these assets are amortized over an estimated useful life of 3 three March 31, 2017 2016 $31,000 $27,000, March 31, 2017 December 31, 2016 $196,000 $227,000, $94,000 2017, $92,000 2018, $10,000 2019, $4,000

Note 6 - Property and Equipment

Note 6 - Property and Equipment	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6 At March 31, 2017 December 31, 2016 March 31, 201 7 December 31, 201 6 Office equipment $ 244,000 $ 244,000 Shop equipment 186,000 173,000 Leasehold improvements 253,000 253,000 683,000 670,000 Less accumulated depreciation 569,000 553,000 Net property and equipment $ 114,000 $ 117,000 Depreciation expense for the three March 31, 2017 2016 $15,000 $14,000

Note 7 - Business Segments

Note 7 - Business Segments	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 7 The Company has two Segment information for the three ended March 31, 201 7 for the company’s business segments follows: CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue 28,000 - - 28,000 Total costs and expenses 758,000 132,000 428,000 1,318,000 Loss from operations 786,000 132,000 428,000 1,346,000 Other (expense) - - (155,000 ) (155,000 ) Net loss $ 786,000 $ 132,000 $ 583,000 $ 1,501,000 Stock compensation expense $ 76,000 $ 2,000 $ 25,000 $ 103,000 Depreciation and amortization $ 37,000 $ 6,000 $ 3,000 $ 46,000 Capital expenditures $ 11,000 $ - $ - $ 11,000 Assets at March 31, 2017 $ 284,000 $ 42,000 $ 955,000 $ 1,281,000 Segment information for the three ended March 31 , 201 6 for the company’s business segments follows: CURA Aegis Corporate Total Revenue $ 1,000 - - $ 1,000 Loss on revenue (22,000 ) - - (22,000 ) Total costs and expenses 447,000 $ 167,000 302,000 916,000 Loss from operations 470,000 167,000 301,000 938,000 Other income - - 1,000 1,000 Net loss $ 470,000 $ 167,000 $ 300,000 $ 937,000 Stock compensation expense $ 21,000 $ 2,000 $ 8,000 $ 31,000 Depreciation and amortization $ 28,000 $ 11,000 $ 2,000 $ 41,000 Capital expenditures $ 15,000 $ - $ - $ 15,000 Assets at March 31, 2016 $ 292,000 $ 105,000 $ 1,632,000 $ 2,029,000

Note 8 - Preferred and Common S

Note 8 - Preferred and Common Stock	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 8 — PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 $0.01 During the three March 31, 2017 200,000 two 3 62,500 40,000 not three March 31, 2016. Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At March 31, 2017 December 31, 2016, 543,221 8,709 534,512 2,592,000 March 31, 2017 $2,538,000 December 31, 2016. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders ’ liquidation preference was $2,592,000 $2,538,000 March 31, 2017 December 31, 2016, 1 $4.00 Class B Preferred Stock At March 31, 2017 December 31, 2016, 67,500 395,000 March 31, 2017 $386,000 December 31, 2016. three March 31, 2017 2016. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders and our Class A Preferred shareholders, Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders ’ liquidation preference was $395,000 $386,000 March 31, 2017 December 31, 2016, 1 $5.00 Series C Preferred Stock At March 31, 2017 December 31, 2016, 15,937,500 16,000,000 first 2017, one 62,500 ’ liquidation preference was $6,375,000 March 31, 2017 $6,400,000 December 31, 2016. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 ’s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. The Series C Preferred shares have no right to receive dividends and have no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis. Series C- 2 At March 31, 2017 December 31, 2016, 25,000,000 2 C- 2 2 $5,000,000 March 31, 2017 December 31, 2016. The Series C- 2 2 may two thirds 2 2 2 2 2 2 2 2 Series C- 3 During 2016, he Company issued a total of 6,042,000 3 $1,510,500. $1,495,000 In connection with the issuance of the Series C- 3 one one three March 31, 2016, $549,000, During the three March 31, 2017 200,000 3

Note 9 - Stock Options

Note 9 - Stock Options	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 9 — STOCK OPTIONS 20 11 20 16 T he 2016 “2016 3,000,000 may 2016 No 2016 March 31, 2017. T he 2011 “2011 3,000,000 may 2011 On occasion, we have granted non-qualified stock options to certain officers, directors and employees that have been outside of established Company Stock Option Plans. All such option grants have been authorized by shareholder approval. During the three March 31, 2017, 235,000 $0.65 $1.00 10 four 25% four As of March 31, 2017, 2,782,000 2011 1,533,000 March 31, 2017, 218,000 2011 No three March 31, 2017 2016. The expense recognized for options that are granted to consultants (i.e., non-employees) reflect fair value, based on updated valuation assumptions using the Black-Scholes valuation model at each measurement period. Such expense is apportioned over the requisite service period of the consultant, which is concurrent with the vesting dates of the various tranches. As of March 31, 2017, 6,900,000 4,750,000 three March 31, 2017 2016, no Summary For the three March 31, 2017 2016, $103,000 $31,000, March 31, 2017, $473,000 1.5 The weighted average grant date fair value of all stock options granted during the three March 31, 2017 2016 $0.76 $0.45, three March 31, 2017 2016 $2,000 zero, The fair value of options granted during the three March 31, 2017 2016 201 7 201 6 Expected Term (years) 6.6% 5.1% Expected forfeiture rate 0.0% 0.0% Risk-free rate 2.1% 2.1% Volatility 130% 132% Dividend yield 0.0% 0.0% Included in the 2016 327,000 2011 first $5.00 The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not believe we have sufficient historical stock option exercise experience on which to base the expected term. The following summarizes the activity of all of our outstanding stock options for the three March 31, 2017: Average Weighted Remaining Average Contractual Aggregate Shares Exercise Price Term (years) Intrinsic Value Outstanding at January 1, 201 7 9,447,000 $ .53 4.8 $ 2,016,000 Granted 235,000 Exercised - - Canceled or expired - - Outstanding at March 31, 2017 9,682,000 $ .54 4.6 $ 4,876,000 Exercisable at March 31, 2017 6,283,000 $ .61 4.2 $ 2,739,000 As of March 31, 2017, $.20 $5.00

Note 10 - Warrants

Note 10 - Warrants	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Stockholders Equity Note Warrants Or Rights [Text Block]	NOTE 10 The following table summarizes the activity of the outstanding warrants as of March 31, 2017: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 201 7 4,218,500 $ .95 (a) 6.1 (b) Granted - Exercised (40,000 ) $ 0.25 Expired (50,000 ) $ 5.00 Outstanding at March 31, 2017 4,128,500 $ 0.88 (a) 5.9 (d) $ 2,187,000 Exercisable at March 31, 2017 3,503,500 $ 0.83 (d) 5.7 (c) $ 2,184,000 ( a) The weighted average exercise price for warrants outstanding as of March 31, 2017 1,750,000 ( b) The weighted average remaining contractual term for warrants outstanding as of March 31, 2017 743,500 ( c) The weighted average remaining contractual term for warrants exercisable as of March 31, 2017 118,500 ( d) The weighted average exercise price for warrants exercisable as of March 31, 2017 1,625,000

Note 11 - Related Party Transac

Note 11 - Related Party Transactions and Commitments	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 11 — RELATED PARTY TRANSACTIONS AND COMMITMENTS We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership, with which one 2014, three May 31, 2018. $6,000 ($75,000 three 9% September 2018 May 2021. three March 31, 2017 2016 $20,000 $19,000, December 31, 2017 2018 $55,000 $75,000, During the first 2017, third vendor to manufacture and assemble the myCadian watch. In connection with this agreement, the Company agreed to a cancellation charge for products purchased on behalf of the Company in the instance that the purchase order is subsequently modified or cancelled. The Company estimates that approximately $30,000 March 31, 2017

Note 12 - Subsequent Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 12 Subsequent to March 31, 2017, 400,000 3

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Consolidation: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% March 31, 2017). March 31, 2017,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.
Reclassification, Policy [Policy Text Block]	Reclassifications: Certain reclassifications may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Equivalents: Cash and equivalents may three may $25,000.
Inventory, Policy [Policy Text Block]	Inventory : Inventory is stated at the lower of cost or market with cost determined under the average cost method. We record provisions for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. The allowance for excess, obsolete or slow-moving inventory was zero March 31, 2017 December 31, 2016.
Receivables, Policy [Policy Text Block]	Accounts Receivable : We carry our accounts receivable at invoice amount less an allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and establish an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. We do not accrue interest on past due invoices. The allowance for doubtful accounts was zero March 31, 2017 December 31, 2016.
Software Property And Equipment [Policy Text Block]	Software, Property and Equipment: Capitalized software, property and equipment are stated at cost. Estimated useful lives are as follows: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the three March 31, 2017 2016 to $46,000 $41,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may three March 31, 2017 2016, no
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments: As defined by U.S. GAAP , one three Level 1: Level 2: Level 3: The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at March 31, 2017. 6% $12,600,000 March 31, 2017.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition and Deferred Revenue: The Company began offering the Z-Coach Aviation program in the first 2016. twelve 30
In Process Research and Development, Policy [Policy Text Block]	Engineering and Development and Patents: Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development includes personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the three March 31, 2017 2016 $30,000 $17,000,
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-based Compensation: FASB Accounting Standards Codification (“ASC”) 718 10 may 718 10. FASB ASC 505 50, FASB ASC 718 20 Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.
Income Tax, Policy [Policy Text Block]	Income Taxes: We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of March 31, 2017, December 31, 2016, no
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share: FASB’s ASC 260 10 March 31, 2017 2016, 72,282,657 59,016,206 625,000 March 31, 2017 2016
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements: FASB Accounting Pronouncements Related to Revenue from Contracts with Customers (Topic 606) In May 2014, 2014 09, 2014 09 2014 09 five may In May 2015, 2015 14, December 15, 2017. March 2016, 2016 08 April 2016, 2016 10, 606. May, 2016, 2016 12, 606. These standards are effective for annual periods beginning after December 15, 2017, The Company continues to evaluate the impact of the adoption of FASB accounting pronouncements related to revenue from Contracts with Customers (Topic 606) Other FASB Accounting Pronouncements In August 2016, 2016 15 Topic 230).” 230, eight December 15, 2017, In June 2016, 2016 13 326) December 15, 2019, On February 25, 2016, 2016 02, December 15, 2018,

Note 2 - Summary of Significa20

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Software, Property and Equipment Estimated Useful Life [Table Text Block]	Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term

Note 6 - Property and Equipme21

Note 6 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, 201 7 December 31, 201 6 Office equipment $ 244,000 $ 244,000 Shop equipment 186,000 173,000 Leasehold improvements 253,000 253,000 683,000 670,000 Less accumulated depreciation 569,000 553,000 Net property and equipment $ 114,000 $ 117,000

Note 7 - Business Segments (Tab

Note 7 - Business Segments (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue 28,000 - - 28,000 Total costs and expenses 758,000 132,000 428,000 1,318,000 Loss from operations 786,000 132,000 428,000 1,346,000 Other (expense) - - (155,000 ) (155,000 ) Net loss $ 786,000 $ 132,000 $ 583,000 $ 1,501,000 Stock compensation expense $ 76,000 $ 2,000 $ 25,000 $ 103,000 Depreciation and amortization $ 37,000 $ 6,000 $ 3,000 $ 46,000 Capital expenditures $ 11,000 $ - $ - $ 11,000 Assets at March 31, 2017 $ 284,000 $ 42,000 $ 955,000 $ 1,281,000 CURA Aegis Corporate Total Revenue $ 1,000 - - $ 1,000 Loss on revenue (22,000 ) - - (22,000 ) Total costs and expenses 447,000 $ 167,000 302,000 916,000 Loss from operations 470,000 167,000 301,000 938,000 Other income - - 1,000 1,000 Net loss $ 470,000 $ 167,000 $ 300,000 $ 937,000 Stock compensation expense $ 21,000 $ 2,000 $ 8,000 $ 31,000 Depreciation and amortization $ 28,000 $ 11,000 $ 2,000 $ 41,000 Capital expenditures $ 15,000 $ - $ - $ 15,000 Assets at March 31, 2016 $ 292,000 $ 105,000 $ 1,632,000 $ 2,029,000

Note 9 - Stock Options (Tables)

Note 9 - Stock Options (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	201 7 201 6 Expected Term (years) 6.6% 5.1% Expected forfeiture rate 0.0% 0.0% Risk-free rate 2.1% 2.1% Volatility 130% 132% Dividend yield 0.0% 0.0%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Average Weighted Remaining Average Contractual Aggregate Shares Exercise Price Term (years) Intrinsic Value Outstanding at January 1, 201 7 9,447,000 $ .53 4.8 $ 2,016,000 Granted 235,000 Exercised - - Canceled or expired - - Outstanding at March 31, 2017 9,682,000 $ .54 4.6 $ 4,876,000 Exercisable at March 31, 2017 6,283,000 $ .61 4.2 $ 2,739,000

Note 10 - Warrants (Tables)

Note 10 - Warrants (Tables)	3 Months Ended
	Mar. 31, 2017
Warrant [Member]
Notes Tables
Share-based Compensation, Activity [Table Text Block]	Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 201 7 4,218,500 $ .95 (a) 6.1 (b) Granted - Exercised (40,000 ) $ 0.25 Expired (50,000 ) $ 5.00 Outstanding at March 31, 2017 4,128,500 $ 0.88 (a) 5.9 (d) $ 2,187,000 Exercisable at March 31, 2017 3,503,500 $ 0.83 (d) 5.7 (c) $ 2,184,000

Note 1 - The Company and Basi25

Note 1 - The Company and Basis of Presentation (Details Textual)	Aug. 25, 2016$ / shares	Mar. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Sep. 30, 2016USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Number of Operating Segments		2
Cash and Cash Equivalents, at Carrying Value		$ 892,000	$ 2,009,000		$ 1,547,000	$ 1,241,000
Working Capital		545,000
Stockholders' Equity Attributable to Parent		196,000	1,583,000
Retained Earnings (Accumulated Deficit)		(76,920,000)	(75,418,000)
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments		$ 4,000,000
Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Cash Needed During the Year to Fund Current and Future Commitments		$ 4,600,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 3,000,000		$ 3,000,000
Debt Instrument, Term		5 years
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 0.50
Conversion of Promissory Notes, Percentage of Market Price		60.00%
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes		10.00%
Senior Convertible Note and Warrants [Member]
Proceeds from Convertible Debt			$ 3,000,000
Senior Convertible Promissory Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%	6.00%
Debt Instrument, Term	5 years	5 years
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.25	$ 0.50
Series C3 Preferred Stock [Member]
Proceeds from Issuance of Private Placement, Gross			$ 1,510,500

Note 2 - Summary of Significa26

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Aug. 25, 2016
Allowance for Doubtful Accounts Receivable, Current	$ 0		$ 0
Depreciation, Depletion and Amortization	46,000	$ 41,000
Research and Development Expense	$ 493,000	$ 492,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	72,282,657	59,016,206
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$ 0		0
Asset Impairment Charges			$ 0	$ 0
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	625,000	625,000
Patents [Member] | General and Administrative Expense [Member]
Research and Development Expense	$ 30,000	$ 17,000
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period	1 year
Senior Convertible Promissory Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%		6.00%		6.00%
Long-term Debt, Fair Value	$ 12,600,000
Commercial Paper [Member] | Collateral Pledged [Member]
Debt Instrument, Collateral Amount	$ 25,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage	56.00%

Note 2 - Summary of Significa27

Note 2 - Summary of Significant Accounting Policies - Property, and Equipment, Estimated Useful Lives (Details)	12 Months Ended
	Dec. 31, 2016
Office Equipment [Member] | Minimum [Member]
Property plant and equipment, useful lives (Year)	5 years
Office Equipment [Member] | Maximum [Member]
Property plant and equipment, useful lives (Year)	7 years
Leasehold Improvements [Member]
Property plant and equipment, useful lives	lesser of useful life or lease term
Computer Software, Intangible Asset [Member]
Property plant and equipment, useful lives (Year)	3 years

Note 3 - 6% Senior Convertibl28

Note 3 - 6% Senior Convertible Notes and Warrants (Details Textual) - USD ($)	Aug. 25, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Sep. 30, 2016
Interest Expense		$ 156,000
Amortization of Debt Discount (Premium)		112,000
Convertible Debt, Noncurrent		$ 655,000		$ 543,000
Private Placement Warrants [Member]
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes	10.00%	10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25	$ 0.50
Class of Warrant or Right, Term		10 years		10 years
Senior Convertible Promissory Notes [Member]
Debt Instrument, Term	5 years	5 years
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%		6.00%
Debt Instrument, Convertible, Conversion Price	$ 0.25	$ 0.50
Debt Instrument, Debt Discount Before Amortization		$ 2,551,000
Interest Expense		156,000
Amortization of Debt Discount (Premium)		112,000
Debt Instrument, Face Amount		3,000,000
Debt Instrument, Unamortized Discount		2,345,000
Convertible Debt, Noncurrent		655,000
Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 3,000,000			$ 3,000,000
Debt Instrument, Term		5 years
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Debt Instrument, Convertible, Conversion Price		$ 0.50
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes		10.00%

Note 4 - Capital Lease Obliga29

Note 4 - Capital Lease Obligation (Details Textual) - Office Equipment [Member]	12 Months Ended
	Dec. 31, 2015USD ($)
Capita Lease, Term	5 years
Capital Leased Assets, Gross	$ 9,000
Capital Lease, Monthly Payment	$ 170
Debt Instrument, Interest Rate During Period	5.30%

Note 5 - Software (Details Text

Note 5 - Software (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Capitalized Computer Software, Amortization	$ 31,000	$ 27,000
Capitalized Computer Software, Net	$ 196,000		$ 227,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year	$ 94,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	92,000
Finite-Lived Intangible Assets, Amortization Expense, Year Three	10,000
Finite-Lived Intangible Assets, Amortization Expense, Year Four	$ 4,000

Note 6 - Property and Equipme31

Note 6 - Property and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Depreciation	$ 15,000	$ 14,000

Note 6 - Property and Equipme32

Note 6 - Property and Equipment - Property and Equipment (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Office equipment	$ 244,000	$ 244,000
Shop equipment	186,000	173,000
Leasehold improvements	253,000	253,000
	683,000	670,000
Less accumulated depreciation	569,000	553,000
Net property and equipment	$ 114,000	$ 117,000

Note 7 - Business Segments (Det

Note 7 - Business Segments (Details Textual)	3 Months Ended
	Mar. 31, 2017
Number of Operating Segments	2

Note 7 - Business Segments - Op

Note 7 - Business Segments - Operation by Segments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Revenue	$ 9,000	$ 1,000
Loss on revenue	(28,000)	(22,000)
Operating costs and expenses	1,318,000	916,000
Loss from operations	1,346,000	938,000
Other income (expense)	(155,000)	1,000
Net loss	1,501,000	937,000
Stock compensation expense	103,000	31,000
Depreciation and amortization	46,000	41,000
Capital expenditures	11,000	15,000
Assets	1,281,000	2,029,000	$ 2,435,000
Loss from operations	1,346,000	938,000
Operating Segments [Member] | CURA Division [Member]
Revenue	9,000	1,000
Loss on revenue	(28,000)	(22,000)
Operating costs and expenses	758,000	447,000
Loss from operations	786,000	470,000
Other income (expense)
Net loss	786,000	470,000
Stock compensation expense	76,000	21,000
Depreciation and amortization	37,000	28,000
Capital expenditures	11,000	15,000
Assets	284,000	292,000
Loss from operations	786,000	470,000
Operating Segments [Member] | Aegis Division [Member]
Revenue
Loss on revenue
Operating costs and expenses	132,000	167,000
Loss from operations	132,000	167,000
Other income (expense)
Net loss	132,000	167,000
Stock compensation expense	2,000	2,000
Depreciation and amortization	6,000	11,000
Capital expenditures
Assets	42,000	105,000
Loss from operations	132,000	167,000
Corporate, Non-Segment [Member]
Revenue
Loss on revenue
Operating costs and expenses	428,000	302,000
Loss from operations	428,000	301,000
Other income (expense)	(155,000)	1,000
Net loss	583,000	300,000
Stock compensation expense	25,000	8,000
Depreciation and amortization	3,000	2,000
Capital expenditures
Assets	955,000	1,632,000
Loss from operations	$ 428,000	$ 301,000

Note 8 - Preferred and Common35

Note 8 - Preferred and Common Stock (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Common stock, shares authorized (in shares)	400,000,000		400,000,000
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Stock Issued During Period, Shares, New Issues		0
Preferred stock, shares authorized (in shares)	100,000,000		100,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01		$ 0.01
Preferred Class A [Member]
Preferred stock, shares authorized (in shares)	3,300,000		3,300,000
Preferred stock, shares outstanding (in shares)	543,221		543,221
Preferred Stock Dividends, Shares	8,709		8,709
Preferred Units, Outstanding	534,512
Dividends Payable	$ 2,592,000		$ 2,538,000
Preferred Stock, Liquidation Preference, Value	$ 2,592,000		$ 2,538,000
Preferred Stock, Liquidation Preference Per Share	$ 4
Preferred Class B [Member]
Preferred stock, shares authorized (in shares)	300,000		300,000
Preferred stock, shares outstanding (in shares)	67,500		67,500
Dividends Payable	$ 395,000		$ 386,000
Preferred Stock, Liquidation Preference, Value	$ 395,000		$ 386,000
Preferred Stock, Liquidation Preference Per Share	$ 5
Series C Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues	15,937,500		16,000,000
Preferred Stock, Liquidation Preference, Value	$ 6,375,000		$ 6,400,000
Preferred Stock, Liquidation Preference Per Share	$ 0.40
Series C2 Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	25,000,000		25,000,000
Preferred stock, shares outstanding (in shares)	25,000,000		25,000,000
Preferred Stock, Liquidation Preference, Value	$ 5,000,000		$ 5,000,000
Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues			6,042,000
Preferred stock, shares authorized (in shares)	10,000,000		10,000,000
Preferred stock, shares outstanding (in shares)	4,822,000		5,022,000
Preferred Stock, Liquidation Preference, Value		$ 549,000
Proceeds from Issuance of Private Placement, Gross			$ 1,510,500
Proceeds from Issuance of Private Placement			$ 1,495,000
Convertible Preferred Stock, Shares Issued upon Conversion	1
Common Stock [Member]
Stock Issued During Period, Shares, New Issues	40,000
Common Stock [Member] | Series C Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	62,500
Common Stock [Member] | Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	200,000
Common Stock [Member] | Warrants [Member]
Stock Issued During Period, Shares, New Issues	40,000
Common Stock [Member] | Conversion of Series C3 Convertible Stock Into Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	200,000
Common Stock [Member] | Conversion of Series C Preferred Stock to Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	62,500

Note 9 - Stock Options (Details

Note 9 - Stock Options (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	235,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.20
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	9,682,000		9,447,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 473,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 182 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.76	$ 0.45
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 2,000	$ 0
Non Plan Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	6,900,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	4,750,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	0	0
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 103,000	$ 31,000
Stock Option Plan 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0
Stock Option Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,782,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	1,533,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	218,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period	0	0
Stock Option Plan 2011 [Member] | Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	235,000		327,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.65
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 1
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Trading Price of Common Stock upon Vesting	$ 5

Note 9 - Stock Options - Stock

Note 9 - Stock Options - Stock Options Valuation Assumptions (Details)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Expected Term (years) (Year)	6 years 219 days
Expected forfeiture rate	0.00%	0.00%
Risk-free rate	2.10%
Volatility	130.00%
Dividend yield	0.00%	0.00%
Minimum [Member]
Expected Term (years) (Year)		5 years 36 days
Risk-free rate		2.10%
Volatility		132.00%

Note 9 - Stock Options - Share-

Note 9 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Outstanding shares (in shares)	9,447,000
Outstanding - weighted average exercise price (in dollars per share)	$ 0.53
Outstanding - weighted average remaining contractual term (Year)	4 years 219 days	4 years 292 days
Outstanding - aggregate intrinsic value	$ 4,876,000	$ 2,016,000
Shares, granted (in shares)	235,000
Weighted average exercise price, granted (in dollars per share)
Shares, canceled or expired (in shares)
Weighted average exercise price, canceled or expired (in dollars per share)
Outstanding (in shares)	9,682,000	9,447,000
Outstanding (in dollars per share)	$ 0.54	$ 0.53
Shares, exercisable (in shares)	6,283,000
Weighted average exercise price, exercisable (in dollars per share)	$ 0.61
Exercisable- weighted average remaining contractual term (Year)	4 years 73 days
Exercisable-aggregate intrinsic value	$ 2,739,000

Note 10 - Warrants (Details Tex

Note 10 - Warrants (Details Textual)	Mar. 31, 2017USD ($)shares
Warrants without Expiration Date, Outstanding	743,500
Warrants without Expiration Date, Exercisable	118,500
Warrants Without Exercise Price, Outstanding	1,625,000
Warrants Not Determined, Exercise Price [Member]
Warrants and Rights Outstanding | $	$ 1,750,000

Note 10 - Warrants - Summary of

Note 10 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)		3 Months Ended		12 Months Ended
		Mar. 31, 2017		Dec. 31, 2016
Outstanding shares (in shares)		9,447,000
Outstanding - weighted average exercise price (in dollars per share)		$ 0.53
Shares, granted (in shares)		235,000
Weighted average exercise price, granted (in dollars per share)
Shares, canceled or expired (in shares)
Weighted average exercise price, canceled or expired (in dollars per share)
Outstanding (in shares)		9,682,000		9,447,000
Outstanding (in dollars per share)		$ 0.54		$ 0.53
Shares, exercisable (in shares)		6,283,000
Weighted average exercise price, exercisable (in dollars per share)		$ 0.61
Exercisable- weighted average remaining contractual term (Year)		4 years 73 days
Exercisable-aggregate intrinsic value		$ 2,739,000
Warrant [Member]
Outstanding shares (in shares)		4,218,500
Outstanding - weighted average exercise price (in dollars per share)	[1]	$ 0.95
Weighted average remaining contractual term, outstanding (Year)		5 years 328 days	[2]	6 years 36 days
Shares, granted (in shares)
Weighted average exercise price, granted (in dollars per share)
Shares, exercised (in shares)		(40,000)
Weighted average exercise price, exercised (in dollars per share)		$ 0.25
Shares, canceled or expired (in shares)		(50,000)
Weighted average exercise price, canceled or expired (in dollars per share)		$ 5
Outstanding (in shares)		4,128,500		4,218,500
Outstanding (in dollars per share)		$ 0.88	[3]	$ 0.95	[1]
Aggregate intrinsic value, outstanding		$ 2,187,000
Shares, exercisable (in shares)		3,503,500
Weighted average exercise price, exercisable (in dollars per share)		$ 0.83
Exercisable- weighted average remaining contractual term (Year)	[4]	5 years 255 days
Exercisable-aggregate intrinsic value		$ 2,184,000
[1]	The weighted average remaining contractual term for warrants outstanding as of March 31, 2017 excludes 743,500 warrants with no expiration date.
[2]	The weighted average exercise price for warrants exercisable as of March 31, 2017 excludes 1,625,000 warrants with no determined exercise price.
[3]	The weighted average exercise price for warrants outstanding as of March 31, 2017 excludes 1,750,000 warrants with no determined exercise price.
[4]	The weighted average remaining contractual term for warrants exercisable as of March 31, 2017 excludes 118,500 warrants with no expiration date.

Note 11 - Related Party Trans41

Note 11 - Related Party Transactions and Commitments (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Oct. 31, 2014	Mar. 31, 2017	Mar. 31, 2016
Operating Leases, Rent Expense		$ 20,000	$ 19,000
Operating Leases, Future Minimum Payments, Remainder of Fiscal Year		55,000
Operating Leases, Future Minimum Payments, Due in Two Years		75,000
Unrecorded Unconditional Purchase Obligation, Purchases		30,000
Director [Member]
Lessee, Operating Lease, Renewal Term	3 years
Monthly Rent Payment under Operating Lease		6,000
Annual Rent Payment under Operating Lease		$ 75,000
Operating Lease, Length of Renewal Option		3 years
Operating Lease, Rate Increase at Renewal Period		9.00%

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - Common Stock [Member] - Conversion of Series C3 Convertible Stock Into Common Stock [Member] - shares	1 Months Ended	3 Months Ended
	May 08, 2017	Mar. 31, 2017
Stock Issued During Period, Shares, Conversion of Convertible Securities		200,000
Subsequent Event [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	400,000